Which diagnostic tests are most effective for confirming a diagnosis of aspergillosis in patients with respiratory symptoms?

Guideline-aligned answer with reasoning, red flags and references. Clinically reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP.

Posted: 22 August 2025Updated: 22 August 2025 Guideline-Aligned (High Confidence) Clinically Reviewed
Dr Kola Tytler MBBS CertHE MBA MRCGPClinical Lead • iatroX

For confirming a diagnosis of aspergillosis in patients presenting with respiratory symptoms, the most effective diagnostic approach combines clinical assessment with targeted laboratory and imaging tests. Serum and bronchoalveolar lavage (BAL) galactomannan antigen testing is a cornerstone, offering high sensitivity and specificity for invasive aspergillosis, especially in immunocompromised patients . Fungal culture and microscopy of respiratory samples, including sputum and BAL fluid, support diagnosis but have lower sensitivity and longer turnaround times . Polymerase chain reaction (PCR)-based assays on respiratory specimens enhance detection rates and can complement galactomannan testing, although standardisation is variable . High-resolution computed tomography (HRCT) of the chest is essential to identify characteristic radiological features such as nodules with halo signs or cavitations, which guide further diagnostic workup . Combining these modalities improves diagnostic accuracy, particularly in complex cases or non-neutropenic patients where clinical presentation may be atypical . Thus, an integrated diagnostic strategy using galactomannan antigen detection in serum and BAL, supported by PCR and imaging, is most effective for confirming aspergillosis in respiratory presentations .

Educational content only. Always verify information and use clinical judgement.